About ABT Molecular Imaging

About company

ABT Molecular Imaging develops a production platform to generate unit doses of molecular imaging drugs for PET scanning at the point of use. ABT Molecular Imaging was founded by Ron and Lynda Nutt in 2006 and where clinical PET was developed beginning in the early 1980s. The company was founded in 2006 by industry experts in the molecular imaging industry. ABT’s investor partners include Intersouth Partners, River Cities Capital, and two TNInvestco Funds, Council & Enhanced Tennessee Fund and Limestone Fund. The company is headquartered in Knoxville, Tennessee.